Skip to content
Acredit

Acredit

  • The Acredit Network
  • About ACREDIT
    • About ACREDIT
    • CMOR
    • Translational Cancer Therapy
    • Ahus Gastrointestinal Radiology (Gastrorad) Research Group
    • Image guided surgery and minimal intervention
    • Clinical and translational cancer research
    • Vacancies
  • About Colorectal Cancer
  • News
  • Research
    • METIMMOX
    • The LARC-RRP study
    • LARC-EX study
    • The OSLO-CoMet study
    • The ImmunoPeCa study
    • The OxyTarget study
    • The MetAction study
    • The EuroPMP COST Action
    • Cure4PMP
    • The PRAVO study
    • The Bone Marrow Micrometastasis in Colorectal Cancer study
  • Privacy Policy
  • Contact Information
Acredit

Research

Research 

Metimmox Success Featured in the News

17/06/202117/06/2021 acredit colorectal cancer, immune system, immunogenicity, Metimmox

The Metimmox trial, which has been running at Norwegian hospitals (Akershus University Hospital, St. Olav’s University Hospital, Haukeland University Hospital,

Read more
Research 

The Value of Anti-Angiogenic Treatments in PMP

10/06/202117/06/2021 acredit angiogenesis, PMP

There is a lot of evidence to suggest anti-angiogenic treatment (treatments that stop new blood vessels from growing) might be

Read more
Research 

New Marker for Risk of Liver Metastasis from Rectal Cancer Identified

09/04/202114/04/2021 acredit

A group of Acredit members, led by Dr Sebastian Meltzer has published a new paper outlining that the higher the

Read more
Research 

EV Phenotype Impact and Function of Monocytes in CRC

19/02/202124/02/2021 acredit colorectal cancer, extracellular vesicles, metastasis, monocytes

New research looking at the impact of tumor-derived extracellular vesicles (EVs) on the phenotype and function of monocytes has been

Read more
Research 

Rectal Tumour Blood Flow May Predict CT Response

25/09/202023/10/2020 acredit

New research looking at the differences in tumour blood flow between patients of different sexes has been published by Acredit’s

Read more
Research 

Review: Tumour Immunogenicity in CRC

07/08/2020 acredit chemotherapy, colorectal cancer, immune system, immunogenicity, radiation, review, tumour microenvironment

CMOR members Erta Kalanxi, Sebastian Meltzer and Anne Hansen Ree have published a new review article looking into the current

Read more
Research 

Incidence and Prevalence Rate of PMP in Europe Estimated

04/06/202004/06/2020 acredit Acredit, Incidence, PMP, Prevalence, Pseudomyxoma peritonei

Acredit members Thale Dawn Patrick-Brown and Kjersti Flatmark have published a new paper on the prevalence and incidence of pseudomyxoma

Read more
Research 

New Paper Looks into Patient-Derived Xenograft Models

25/05/202027/05/2020 acredit cabazitaxel, capecitabine, irinotecan, oxaliplatin, Peritoneal Metastasis, regorafenib, Xenograft

Acredit’s Karianne Giller Fleten has published a paper entitled “Experimental treatment of mucinous peritoneal metastases using patient-derived xenograft models”.  In

Read more
Research 

New paper highlights value of circulating FLT3LG in immunogenic response to chemotherapy

24/04/2020 acredit Acredit, colorectal cancer, FLT3, FLT3LG

An Editorial written by the Kroemer group from the Gustave Roussy Comprehensive Cancer Institute highlights the recent research by Anne

Read more
Research 

Molecularly Matched Therapy and Outcomes in End-Stage Cancers

26/03/202027/03/2020 acredit MetAction, Precision Medicine

Lead Acredit professors Anne Hansen Ree and Kjersti Flatmark have published a paper outlining the final results from the MetAction

Read more
  • ← Previous
Copyright © 2023 Acredit. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.